Clinical Trial Detail

NCT ID NCT02989844
Title QUILT-3.035: Relapse Prophylaxis With ALT-803 for AML and MDS Pts Following Allo HSCT
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

ALT-803

Age Groups: adult senior

No variant requirements are available.